If the medical information you are seeking is not available for this territory please send your enquiries regarding our pharmaceutical products to email@example.com or enquiries regarding our interventional medicine products to firstname.lastname@example.org
Or visit our Contact Us page for Medical Information contacts
Adverse Event Reporting
To report a suspected adverse event associated with any of our products please contact: email@example.com
Investigator Initiated Studies (IIS) at BTG
BTG is committed to supporting independent research in the form of IISs that further the understanding of diseases and their treatment with the ultimate goal of helping patients. Our support of IISs provides a unique opportunity for physicians to explore areas of mutual scientific interest, and build scientific knowledge of disease management and the role that BTG therapies can play.
For more information on the Investigator Initiated Studies program at BTG or for answers to any questions about the process, please email: firstname.lastname@example.org
Grants Programme at BTG
BTG is committed to promoting excellence in patient care and providing educational information to the medical community. To this end, we award grants and support projects that pertain to topics, events, or societies, or meet certain objectives that are relevant to BTG’s business and/or therapeutic classes.
Medical innovation has the power to improve human health and we look forward to continuing to support educational activities that are objective, balanced and scientifically rigorous. Our aim is to ensure all these events are beneficial to the medical or scientific community, and advance patient care.
If you have questions about the Grants Programme at BTG, please email the Grants Administrator at email@example.comRead more